Radioembolization with 90Y Microspheres: Angiographic and Technical Considerations
Tóm tắt
Từ khóa
Tài liệu tham khảo
El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83
Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 11:914–921
Seifert JK, Cozzi PJ, Morris DL (1998) Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol 14:175–183
Clark TW, Soulen MC (2002) Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol 13:S245–S252
Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171
Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739
Brown KT, Nevins AB, Getrajdman GI, et al. (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822–828
MDS Nordion (2004) TheraSphere yttrium-90 microspheres package insert. MDS Nordion, Kanata, Canada
SIRTeX Medical (2004) SIR-Spheres yttrium-90 microspheres package insert, SIRTeX Medical, Lane Cove, Australia
Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248
Ingold JA, Reed GB, Kaplan HS, Bagshaw MA (1965) Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med 93:200–208
Stubbs RS, Cannan RJ, Mitchell AW (2001) Selective internal radiation therapy (SIRT) with 90-yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48:333–337
Geschwind JF, Salem R, Carr BI, et al. (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127:S194–S205
Carr BI (2004) Hepatic arterial 90-yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 10:S107–S110
Gray B, Van Hazel G, Hope M, et al. (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720
Van Hazel G, Blackwell A, Anderson J, et al. (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85
Salem R, Lewandowski RJ, Atassi B, et al. (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627–1639
Touzios JG, Kiely JM, Pitt SC, et al. (2005) Neuroendocrine hepatic metastases: Does aggressive management improve survival? Ann Surg 241:776–783, discussion 783–775
Romano W (2005) Personal communication. Interventional Radiology, Beaumont Hospital, Royal Oak, MI
Salem R, Thurston KG (2006) Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17:1251–1278
Goin JE, Salem R, Carr BI, et al. (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213
Goin JE, Salem R, Carr BI, et al. (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16:195–203
Rhee TK, Omary RA, Gates V, et al. (2005) The effect of catheter-directed ct angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 16:1085–1091
Gray BN (2003) Use of SIR-Spheres in patients with impaired liver function. Safety Notice. Sirtex Medical, Lane Cove, Australia
Salem R, Lewandowski R, Roberts C, et al. (2004) Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345
Murthy R, Xiong H, Nunez R, et al. (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937–945
Gray BN, Burton MA, Kelleher D, Klemp P, Matz L (1990) Tolerance of the liver to the effects of yttrium-90 radiation. Int J Radiat Oncol Biol Phys 18:619–623
Murthy R, Nunez R, Szklaruk J, et al. (2005) Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 25 (Suppl 1):S41–S55
Stubbs RS, Cannan RJ, Mitchell AW (2001) Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 5:294–302
Liu DM, Salem R, Bui JT, et al. (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16:911–935
Covey AM, Brody LA, Maluccio MA, Getrajdman GI, Brown KT (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542–547
Cosin O, Bilbao JI, Alvarez S, de Luis E, Alonso A, Martinez-Cuesta A (2007) Right gastric artery embolization prior to treatment with yttrium-90 microspheres. Cardiovasc Intervent Radiol 30:98–103
Uflacker R, Feldman CJ (1997) Atlas of vascular anatomy: an angiographic approach. Williams & Wilkins, Baltimore
Yip D, Allen R, Ashton C, Jain S (2004) Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 19:347–349
Goin JE, Dancey JE, Hermann GA, Sickles CJ, Roberts CA, MacDonald JS (2003) Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study. World J Nucl Med 2:216–225
Raju GS, Bardhan KD, Royston C, Beresford J (1999) Giant gastric ulcer: its natural history and outcome in the H2RA era. Am J Gastroenterol 94:3478–3486
Eaden JA, Roberts-Thomson IC (2001) Gastrointestinal: giant gastric ulcers. J Gastroenterol Hepatol 16:573
Arora R, Soulen MC, Haskal ZJ (1999) Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol 10:1351–1356
Kadir S, Brothers MF (1991) Atlas of normal and variant angiographic anatomy. 1st ed. Saunders, Philadelphia
Lewandowski R, Salem R (2004) Incidence of radiation cholecystitis in patients receiving Y-90 treatment for unresectable liver malignancies. J Vasc Interv Radiol 15:S162
Funaki B (2002) Endovascular intervention for the treatment of acute arterial gastrointestinal hemorrhage. Gastroenterol Clin North Am 31:701–713
Finch IJ (1992) Use of the Palmaz stent in ostial celiac artery stenosis. J Vasc Interv Radiol 3:633–635, discussion 636–637
Glickerman DJ, Hathaway PB, Hatsukami T, Daly CP, Althaus S, Kohler TR (1997) Transluminal treatment of a celiac artery pseudoaneurysm with a stent graft occlusion device. Cardiovasc Intervent Radiol 20:466–469
Gotsman I, Verstandig A (2001) Intravascular stent implantation of the celiac artery in the treatment of chronic mesenteric ischemia. J Clin Gastroenterol 32:164–166
Razavi M, Chung HH (2004) Endovascular management of chronic mesenteric ischemia. Tech Vasc Interv Radiol 7:155–159
Kim HC, Chung JW, Lee W, Jae HJ, Park JH (2005) Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 25 (Suppl 1):S25–S39
Matsumoto AH, Selby JB Jr, Tegtmeyer CJ, et al. (1994) Recent development of rigors during infusion of urokinase: Is it related to an endotoxin? J Vasc Interv Radiol 5:433–438